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Abstract
Emerging antibiotic resistance threatens human health. Gut microbes are an epidemiologically important reservoir of
resistance genes (resistome), yet prior studies indicate that the true diversity of gut-associated resistomes has been
underestimated. To deeply characterize the pediatric gut-associated resistome, we created metagenomic recombinant
libraries in an Escherichia coli host using fecal DNA from 22 healthy infants and children (most without recent antibiotic
exposure), and performed functional selections for resistance to 18 antibiotics from eight drug classes. Resistance-
conferring DNA fragments were sequenced (Illumina HiSeq 2000), and reads assembled and annotated with the PARFuMS
computational pipeline. Resistance to 14 of the 18 antibiotics was found in stools of infants and children. Recovered genes
included chloramphenicol acetyltransferases, drug-resistant dihydrofolate reductases, rRNA methyltransferases, transcrip-
tional regulators, multidrug efflux pumps, and every major class of beta-lactamase, aminoglycoside-modifying enzyme, and
tetracycline resistance protein. Many resistance-conferring sequences were mobilizable; some had low identity to any
known organism, emphasizing cryptic organisms as potentially important resistance reservoirs. We functionally confirmed
three novel resistance genes, including a 16S rRNA methylase conferring aminoglycoside resistance, and two tetracycline-
resistance proteins nearly identical to a bifidobacterial MFS transporter (B. longum s. longum JDM301). We provide the first
report to our knowledge of resistance to folate-synthesis inhibitors conferred by a predicted Nudix hydrolase (part of the
folate synthesis pathway). This functional metagenomic survey of gut-associated resistomes, the largest of its kind to date,
demonstrates that fecal resistomes of healthy children are far more diverse than previously suspected, that clinically
relevant resistance genes are present even without recent selective antibiotic pressure in the human host, and that cryptic
gut microbes are an important resistance reservoir. The observed transferability of gut-associated resistance genes to a
gram-negative (E. coli) host also suggests that the potential for gut-associated resistomes to threaten human health by
mediating antibiotic resistance in pathogens warrants further investigation.
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Introduction
Increasing antibiotic resistance in human pathogens threatens to
render many bacterial infections untreatable [1–3]. Human
commensal microbiota harbor numerous functional antibiotic
resistance genes which, in aggregate, comprise the human gut-
associated resistome [4,5]. These genes can be exchanged among
gastrointestinal microbes [6], including potential pathogens,
particularly during host stress [7]. Therefore, characterizing the
diversity and mobility of the commensal resistome is essential to
understand the dissemination of multidrug resistance in hospitals
and communities. The establishment of human gut-associated
resistomes is ideally studied in the pediatric fecal microbiota. This
microbial community is dynamic in early life: a newborn’s sterile
gut is colonized immediately after birth, and the population
structure then fluctuates rapidly for several years until it attains a
composition that likely persists into adulthood [8–10]. Alterations
to the microbiota during this critical developmental period may
permanently alter both its phylogenetic composition and its
associated resistome. Exposure to a fairly limited set of antibiotics
(mostly beta-lactams, macrolides, and folate-synthesis inhibitors) is
common in children [11–13], and resistance to beta-lactams,
tetracyclines, sulfonamides, macrolides, and chloramphenicol has
been reported in infant gut microbiota [14–17]. However,
previous functional investigations of human fecal microbiota
suggest that pediatric resistome diversity may have been signifi-
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cantly underestimated by culture- and PCR-based studies [5].
Moreover, though culture- and PCR-based studies may identify
resistance genes and phenotypes, the association of resistance
genes with mobile genetic elements, a crucial risk factor for
dissemination of resistance, is not readily assessed with those
methodologies.
Our experimental design was optimized to capture a maximally
diverse sample of the pediatric gut resistome, to identify
mobilizable resistance genes at greatest risk for dissemination,
and to select for clinically-relevant and novel resistance genes. To
deeply characterize the fecal resistome of 22 healthy pediatric
clinic patients aged 1 month to 19 years, we coupled functional
metagenomic selections with next-generation (Illumina platform)
sequencing and a recently developed pipeline for high-throughput
assembly, and annotation of functionally-selected DNA (PAR-
FuMS, Parallel Annotation and Reassembly of Functional
Metagenomic Selections) [18]. We sought to optimally represent
the pediatric gut resistome by maximizing both the number of
subjects included (22, an order of magnitude higher than prior
functional metagenomic studies of gut-associated resistomes [5])
and the diversity of functional resistance screens (18 antibiotics
representing eight drug classes). Because metagenomic (microbial
community DNA) libraries created in a model Gram-negative
(Escherichia coli) host models the potential transfer of resistance
genes from native intestinal microbes to human pathogens, we
were able to select for resistance genes with the most potential to
confer resistance to human pathogens, regardless of the genes’
functions in their native hosts. This protocol also facilitates novel
gene discovery because antibiotic resistance is detected by
functional selection rather than by homology to previously
described sequences. Finally, because resistance genes are identi-
fied on contigs 1–5 kb in length, we are able to identify resistance
genes at greatest risk for dissemination by virtue of their close
association with mobile genetic elements.
Results
Population Characteristics
There were no significant differences between infants and older
children and adolescents in library size or clinical characteristics
(Table 1). One child was exposed to antibiotics in the month
before sample donation, and one infant’s stool yielded ciproflox-
acin-resistant E. coli in a predecessor study [19].
Antibiotic Resistance Phenotype
Antibiotic resistance in the metagenomic libraries was stratified
by subject age (infants ,= 12 months, children and adolescents
.12 months of age); with the sole exception of gentamicin, there
was no significant difference between the groups in library
resistance phenotype (Fig. 1). All libraries yielded E. coli
transformants resistant to tetracycline, trimethoprim, trimetho-
prim-sulfamethoxazole, D-cycloserine, chloramphenicol, and pen-
icillin. Decreased susceptibility was also found (though not
uniformly) to aminoglycosides, glycylcyclines, and most beta-
lactam classes.
Resistance Genetics
There were 2489 contigs identified that bore at least one gene
with predicted antibiotic resistance function. 840 of these belonged
to multidrug resistance elements (defined as contigs bearing
multiple resistance genes or a resistance gene and a transporter;
778 of these had multiple distinct antibiotic resistance genes, and
62 encoded resistance and transport proteins), 56 were single
resistance genes syntenic with a mobile element (e.g. integron,
transposon) and 14 belonged to multidrug-resistance elements
syntenic with a mobile element (Fig. S1).
Beta-lactam Resistance
Genes from all four Ambler beta-lactamase classes were
identified in infants, and classes A, C, and D were found in
children and adolescents. Class A contained clusters of beta-
lactamases similar to cephalosporinases previously identified in
human fecal microbiota [5], and 12 unique proteins with ,55%
identity to any known beta-lactamase. A diverse set of predicted
class A extended-spectrum beta-lactamases (ESBLs), including
members of the TEM, SHV, CTX-M, and VEB protein families,
were identified. Genes encoding members of the aforementioned
Class A ESBL protein families were found in 4 of the 22 donors,
which greatly exceeds previously reported rates of ESBL carriage
in healthy children [20]. A fifth group of beta-lactamases,
CLOBOL, was comprised of proteins with high amino acid
identity to the putative beta-lactamase CLOBOL_04087 from
Clostridium boltae ATCC BAA-613 (GenBank Accession
NZ_ABCC02000033.1). The function of CLOBOL has not been
experimentally verified, and although it is not a known ESBL, it
clustered with Class A ESBL protein families SHV, CTX-M, and
TEM on an approximate maximum-likelihood phylogenetic tree
Table 1. Clinical characteristics of fecal sample donors.






Female 4 (50%) 6 (42.8%)
Male 4 (50%) 8 (57.1%)
Antibiotic exposure in the last month
Yes 0 1 (7.1%)
No 7 (87.5%) 13 (92.8%)
Unknown 1 (12.5%) 0
Antibiotic-resistant bacteria cultured from stool*
Yes 1 (12.5%) 0
No 7 (87.5%) 14 (100%)
Household contact taking antibiotics in the last month
Yes 1 (12.5%) 3 (21.4%)
No 7 (87.5%) 10 (71.4%)
Unknown 0 1 (7.1%)
Diarrhea in the last year
Yes 3 (37.5%) 2 (14.3%)
No 5 (62.5%) 10 (71.4%)
Unknown 0 2 (14.3%)
Metagenomic Library Size (GB)
Median 6.42 5.93
Range 0.65–17.2 0.02–26.45
Infant and child groups were compared using a two-tailed Fisher’s Exact Test
for categorical data and the Wilcoxon rank-sum test for continuous data. There
was no significant difference between infants and children for any clinical
variable. Resistant bacteria were cultured and clinical data were collected in a
previously published study [19].
doi:10.1371/journal.pone.0078822.t001
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(Fig. 2). CLOBOL was found in 8 of the 20 subjects (2 infants, 6
children ,11 years old) and was closely associated with
mobilization elements, which suggests significant dissemination
of this poorly-understood beta-lactamase in this cohort of healthy
pediatric clinic patients.
We found both pathogen-identical and novel putative beta-
lactamase genes syntenic with mobile elements; these genes were
often found in multiple genetic contexts, highlighting the
dissemination of these genes within the gut microbiota of healthy
children and adolescents. A beta-lactamase gene identical to one
found on the drug-resistant Neisseria gonorrheae plasmid pJD4
(GenBank Accession NP_052173) [21] and with 99% identity to
a known TEM ESBL (GenBank Accession AAL29436) [22], was
also found in two genetic contexts with high nucleotide identity to
pathogens extending beyond the gene boundaries: (i) on fragments
with 98% identity to E. coli plasmids pAPEC-O2-R (GenBank
Accession NC_006671) [23] and p838C-R1 (GenBank Accession
HQ201416.1), and (ii) on fragments with 99% identity to the
genome of the invasive pathogen Haemophilus influenzae R2866
(GenBank Accession CP002277.1) [24]. A transposon-proximate
Class D beta-lactamase identical to an OXA-10 beta-lactamase
reported in the genome sequence of Bacteroides sp. D22 (GenBank
Accession NZ_GG774809) was found adjacent to a clindamycin
resistance determinant (GenBank Accession NZ_GG705234),
providing an example of disseminated resistance both to beta-
lactams and a drug often used the treatment of beta-lactam-
resistant Gram-positive infections [25].
Aminoglycoside Resistance
Diverse predicted aminoglycoside acetyltransferases, phospho-
transferases (Fig. 3), and adenylyltransferases were identified, as
were several rRNA methylases (Table S6 in File S1), which
presumably confer resistance via target protection. [26] A novel
transposase-associated aminoglycoside phosphotransferase
(F33GE_12) was only 52% identical to any known phosphotrans-
ferase, and nucleotide BLAST of the source contig against the
NCBI nt and wgs databases revealed only low identity to several
Firmicutes over one-third of the contig length, suggesting a cryptic
source organism for this mobilizable resistance gene at risk for
dissemination. Pathogen-homologous sequences were also found:
one contig (F06RAGE_4) was identical to part of the Clostridium
difficile 2007855 genome (GenBank Accession FN665654). The
aminoglycoside-20 phosphotransferase Ib encoded on this C.
difficile-identical sequence was 99% identical to one identified in
Enterococcus faecium (GenBank Accession 3HAM_A) [27].
We also characterized a novel 16S rRNA methylase with only
42% amino acid identity to an rRNA methylase from Enterobacter
cloacae strain 115–824A (GenBank Accession JN968578). This
Figure 1. Antibiotic selections for which resistance was observed. The percent of libraries from infants (N = 8) and children and adolescents
(N = 12) generating colonies resistant to 14 antibiotics is plotted. Two libraries that were ,0.1 GB in size were excluded, as they did not have enough
genetic diversity to accurately represent the resistance in their source metagenome. Not shown are four antibiotics for which no resistance was
found: ciprofloxacin, meropenem, colistin, and cefepime.
doi:10.1371/journal.pone.0078822.g001
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rRNA methylase generates extreme resistance to gentamicin and
amikacin, with clonal growth observed at 1024 ug/mL and
2048 ug/mL respectively (Table 2); clones remained susceptible
to the closely related aminocyclitol spectinomycin (MIC 32 ug/
mL for both clones and controls).
Chloramphenicol Resistance
Genes encoding predicted chloramphenicol acetyltransferases
were commonly found: 22 metagenomic libraries contained 48
examples of these genes. Three chloramphenicol acetyltransferases
syntenic with conjugative transfer proteins (TraG) or plasmid
mobilization proteins (MobA/MobL) had low nucleotide identity
to any known microbial genomes or plasmids in the NCBI nt or
wgs databases, indicating that poorly characterized microbes
might pose a risk for dissemination of chloramphenicol resistance
genes (Table S7 in File S1). A fourth mobile resistance gene
encoding a probable transposase-associated major facilitator
superfamily (MFS) chloramphenicol transport protein, was iden-
tical over 98% of the total contig length to the Corynebacterium
resistens plasmid pJA144188 (GenBank Accession NC_014167),
which harbors nine other resistance genes and was recently
sequenced from an isolate causing a bloodstream infection [28].
Several putative transcriptional regulators were identified, many
belonging to the marCRAB locus regulating various microbial
functions, including antibiotic resistance and stress response [29].
Constitutive expression of the marA transcriptional regulator and
its homologs SoxS and Rob induce transferable antibiotic resistance
in various microorganisms; all three were found in our samples
[30,31]. MarA and other genes in the marCRAB locus were also
found in beta-lactam and tetracycline selections, consistent with
the known activity of the mar regulon. Although these transcrip-
tional regulators are only capable of generating antibiotic
resistance in a host organism (such as Salmonella enterica or our
model recipient E. coli) in which they can act to upregulate efflux
pumps, their presence in healthy children is significant because
they most likely reflect the presence of antibiotic-resistant E. coli,
which, in addition to being a common component of the gut
microflora, is also an important human pathogen.
Figure 2. Unrooted approximate maximum-likelihood phylogenetic tree constructed using the predicted amino acid sequences of
all beta-lactamases in the study set. Ambler classes are color-coded as indicated in the legend (upper right). At the terminus of each branch, the
number of unique amino acid sequences in the terminal cluster is indicated. Branches with identity to extended-spectrum beta-lactamases (ESBLs)
are numbered I–V and their putative ESBL classification is listed in the lower left legend of selected genes. A Class D beta-lactamase with high identity
to a known OXA-10 is also numbered (VI) and included in the lower left legend. Genes included in the lower left legend that were syntenic with
mobile genetic elements are bolded and marked with a 1. Clusters of sequences with ,55% ID to any known beta-lactamase are marked with a `.
Nodes with a Shimodaira-Hasegawa (SH) value .=0.7 are starred. The Shimodaira-Hasegawa score provides a measure of confidence in tree
topology, with a maximum score (highest confidence) of 1.0 [52].
doi:10.1371/journal.pone.0078822.g002
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Tetracycline and Tigecycline Resistance
All three tetracycline resistance (tet) gene categories (ribosomal
protection proteins, MFS and multi antimicrobial extrusion
(MATE) transport proteins, and flavin-dependent monooxygen-
ases) were identified (Table S8 in File S1), with multiple tet genes
often found on the same DNA fragment. Several homologs of the
Bacteroides fragilis conjugative transposon CTn341(GenBank Acces-
sion AY515263) [32] encoded TetQ ribosomal protection proteins
syntenic with rteA, which regulates tetracycline-induced conjuga-
tive transposons [33]. One large (6 kb) contig encoding a TetW
ribosomal protection protein and a TraG family conjugative
transfer protein had very limited identity to sequences in the NCBI
nt and wgs databases (homology to various Clostridiales over only
half its length), implicating a heretofore uncharacterized organism
as a source of mobilizable resistance.
In tigecycline selections, only sequences encoding flavin-
dependent monooxygenases (TetX1 and TetX2) were found
(Table S9 in File S1) on contigs homologous with the ermF region
of the tetracycline-inducible Bacteroides thetaiotaomicron CTnDOT
conjugative transposon (GenBank Accession AJ311171) [34],
which encodes TetX1, TetX2 and an aminoglycoside adenylyl-
transferase. TetX modifies tigecycline, and TetX1 has been found
in Bacteroides strains with increased tigecycline MICs [35].
Two putative MFS transporters not previously known to confer
antibiotic resistance were confirmed to generate tetracycline
resistance in the E. coli host. Each was .98% identical to an
MFS transporter in Bifidobacterium longum s. longum JDM301; both
conferred resistance to tetracycline (MIC 32 ug/mL) and oxytet-
racycline (MIC 32–64 ug/mL).
Cycloserine Resistance
Contigs bearing genes that encoded D-ala-D-ala ligase were
found to confer cycloserine resistance in all metagenomic libraries,
possibly secondary to overexpression of plasmid-borne D-ala-D-
ala ligase or D-alanine racemase by the E. coli host [36]. Notably, a
contig (F30CY_50) bearing a D-ala-D-ala ligase, syntenic with a
RecR recombination protein and a penicillin binding protein
homologous to the penicillin-insensitive PBP2b, had a nearly
identical (98%) protein sequence to several group D streptococcus
(Streptococcus bovis) strains (Table S12 in File S1). Other contigs with
D-ala-D-ala ligases syntenic with mobilization elements
(F16CY_74, F18CY_75) had identity to uncultured organisms
over ,70% of the total fragment length (Table S1 in File S1).
Trimethoprim and Trimethoprim-sulfamethoxazole
Resistance
Genes encoding drug-resistant dihydrofolate reductase A were
present in all libraries, and were frequently associated with
thymidylate synthase and occasionally with aminoglycoside
adenylyltransferases, MATE efflux proteins, and macrolide-
lincosamide-streptogramin ABC transporters (Tables S10, S11 in
File S1). Some contigs encoding dihydrofolate reductase and a
Figure 3. Unrooted approximate maximum-likelihood phylo-
genetic tree constructed using the predicted amino acid
sequences of all aminoglycoside aminotransferases and phos-
photransferases in the study set. Enzyme classes are color-coded as
indicated in the legend. At the terminus of each branch, the name of
the source contig is listed. Aminoglycoside phosphotransferases that
were syntenic with aminoglycoside acetyltransferases are indicated
with purple bold text and marked with a `. Genes syntenic with a
mobile element are bolded and marked with a 1. Nodes with a
Shimodaira-Hasegawa (SH)-value .=0.7 are starred.
doi:10.1371/journal.pone.0078822.g003
Table 2. Putative novel resistance genes.
Sample Name Protein type
Antibiotic resistance (MIC ug/mL;
control MIC, ug/mL) Notes
19GentORF 16S rRNA methylase Gentamicin (.1024; control 16), Amikacin
(.2048; control 32)
42% amino acid identity to any known rRNA methylase
21MFSORF MFS efflux protein Tetracycline (32; control 4), Oxytetracycline
(64; control 2)
99% amino acid identity to MFS transporter identified in
Bifidobacterium longum s. longum JDM301
30MFSORF MFS efflux protein Tetracycline (32; control 4), Oxytetracycline
(32; control 2)
98% amino acid identity to MFS transporter identified in
Bifidobacterium longum s. longum JDM301
30NudixORF NUDIX hydrolase Trimethoprim (512; control 32), Trimethoprim-
Sulfamethoxazole (32/608; control 2/38)
100% amino acid identity to Nudix hydrolase from
Lachnospiraceae bacterium 7_1_58FAA.
These genes were not previously known to generate resistance, yet their resistance function was confirmed when the ORFs encoding them were cloned into E. coli.
doi:10.1371/journal.pone.0078822.t002
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mobilization element had high nucleotide identity to known
commensals (e.g. F24TRSX_31, with .98% identity to Streptococ-
cus salivarius (GenBank Accession CP002888.1)) [37]. Others were
similar to pathogens: F30TRSX_13 had 99% identity to the
Klebsiella pneumoniae plasmid pJIE137 (GenBank Accession
EF219134), which is closely related to the p271a plasmid carrying
the NDM-1 (New Delhi metallobetalactamase) that has been
implicated in serious infections with carbapenem-resistant Gram-
negative bacteria [38]. Several contigs with multiple resistance
genes or mobilization elements were homologous to other
microbes over only one-third of their total length (F11TRSX_80,
F19TRSX_23), underscoring the potential importance of uncul-
tured gut microbes harboring transferable resistance genes.
We also identified a putative novel mechanism of antibiotic
resistance: a contig encoding a Nudix hydrolase identical to one
reported in Lachnospiraceae bacterium 7_1_58FAA (GenBank
accession NZ_ACTW01000031) was found to confer resistance
to both trimethoprim (MIC 512 ug/mL trimethoprim; control
MIC 32 ug/mL) and trimethoprim-sulfamethoxazole (MIC 32/
608 ug/mL trimethoprim/sulfamethoxazole; control MIC 2/
32 ug/mL) in the E. coli host. There are no prior reports of such
resistance. Although this enzyme functions early in the pterin
branch of the folate synthesis pathway [39], the exact mechanism
of resistance is unknown.
Discussion
Using high-throughput functional metagenomics, we captured a
cohort of resistance genes from 22 healthy pediatric clinic patients
representing greater molecular and mechanistic diversity than in
any prior reports of antibiotic resistance in pediatric fecal
microbiota [14–17]. Moreover, this population of healthy infants,
children and adolescents harbored a diverse array resistance genes
associated with mobilization elements and therefore poised for
dissemination. The scale of this study, an order of magnitude
larger than prior functional metagenomic studies of the human gut
microbiota, was facilitated by the novel high-throughput coupling
of next-generation sequencing with PARFuMS, a computational
pipeline that assembles and annotates short-read sequence data
from up to 200 functional selections in parallel, allowing
dramatically increased throughput at ,1% of the cost of
Sanger-based methods [18] (details in File S1). Specifically, genes
encoding all Ambler beta-lactamase classes were present, including
pathogen-identical and novel proteins. Likewise, all major
molecular mechanisms in the tetracycline-resistance family were
represented. Chloramphenicol acetyltransferases were commonly
found in this cohort, as were multiple-antibiotic-resistance
transcriptional regulators (MarA and its homologs SoxS and
Rob). All major classes of aminoglycoside-modifying enzymes were
detected, as well as rRNA methyltransferases. Presumed drug-
resistant dihydrofolate reductases and D-ala-D-ala ligases were
present in every metagenomic library. Even some resistance genes
for which antibiotic selections were not performed (e.g. macrolide-
lincosamide-streptogramin resistance genes) were identified via
proximity to other resistance genes. The use of an E. coli host
organism facilitated detection of resistance genes with demonstra-
ble ability to confer resistance to a model Gram-negative
pathogen, and included many contigs with high sequence identity
to widely varied organisms (commensals, pathogens, and both
Gram-positive and –negative bacteria), representing a true cross-
section of the fecal microbial community.
Observed antibiotic resistance phenotypes were similar in all
members of this group of healthy pediatric clinic patients, and
nearly every resistance gene class was found in both infant and
child and adolescent age groups, strongly suggesting that the fecal
resistome is established early in life. Although the limited clinical
information associated with these archival samples precludes
examining any association between antibiotic and other environ-
mental exposures (e.g. family members, pets [10,40]) and
resistance phenotypes and genotypes, subject or family member
exposure to several of the agents tested (tigecycline, D-cycloserine,
tetracycline, and chloramphenicol) were extremely unlikely in this
cohort. The capture of resistance genes against these agents, and
the presence of resistance to tetracycline, chloramphenicol, and
cycloserine in all libraries, suggests that, in some cases, the
resistome is established independent of antibiotic selection in the
host. In particular, elevated tigecycline MICs in our E. coli host
were found in several libraries even though the fecal samples were
collected before this agent was introduced [41]. Decreased
tigecycline susceptibility was conferred by TetX1 and TetX2,
which likely encodes a tetracycline-degrading enzyme similar to
tetX; this presumably conferred decreased susceptibility to
tigecycline due to structural similarities between tetracycline and
tigecycline. These findings suggest a potential role for functional
metagenomics in predicting emerging resistance to new antibiotics
and improving surveillance and control of multidrug-resistant
organisms.
The pediatric fecal resistome is potentially accessible to
pathogens, so resistance genes associated with mobile elements
deserve special attention due to their increased potential for
dissemination. While some familiar mobile resistance genes were
identified, such as the TEM beta-lactamase associated with E. coli
R1 plasmids and tet family genes associated with Bacteroides
conjugative transposons, we also identified mobilizable resistance
genes on contigs with little identity to known microbial genomes or
mobile genetic elements archived in the NCBI nt and wgs
databases in every class of antibiotics assayed. This demonstrates
that poorly characterized uncultivated organisms in the gut
microbiota are important sources of resistance genes, even to
rarely used antibiotics. The detection of chloramphenicol resis-
tance in every library was especially surprising; prior culture-based
studies of pediatric fecal microbiota detect chloramphenicol
resistance less frequently than resistance to other agents [14–
17,42]. The factors underlying the common chloramphenicol
resistance in the uncultured fecal microbiota are unclear, although
selective pressures in the environment such as agricultural use of
chloramphenicol [43], or vestigial resistance from an era when
chloramphenicol was more widely used in humans, are plausible.
Clearly, the pediatric fecal microbiota must be further character-
ized as an important reservoir of mobilizable resistance against
common and rarely used antibiotics, particularly if the rise of
multidrug-resistant pathogens spurs reintroduction of rarely used
agents [44].
Novel resistance mechanisms encoded by contigs nearly
identical to Bifidobacterial genomes illustrate the utility expressing
genes in a model Gram-negative organism to identify potential
interactions between probiotic and pathogenic gut microbes.
Although many safety assessments of food-grade and probiotic
organisms have been performed [45], the omission of functional
selections in these experiments might have underestimated the
potential of these organisms to act as resistance gene reservoirs.
For instance, we show that two proteins .98% identical to MFS
transporters from B. longum s. longum JDM 301 generated high-level
tetracycline and oxytetracycline resistance in E. coli, yet a detailed
computational analysis of this strain did not associate these
transporters with tetracycline resistance [46]. Although these
results must be interpreted with caution, as the risk of horizontal
gene transfer from probiotic to pathogen in the absence of a
Mobilizable Pediatric Gut Resistomes
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mobile genetic element is low, this example of a widely-used food-
grade organism with the potential to donate high-level antibiotic
resistance to a pathogenic host, regardless of the gene’s function in
its native context illustrates that an organism’s potential to act as a
reservoir of resistance genes is best assayed using functional
metagenomics, a key complement to culture-based and in-silico
approaches.
Finally, we report trimethoprim-sulfamethoxazole resistance
conferred by a contig encoding a putative Nudix hydrolase, which
depyrophosphorylates dihydroneopterin triphosphate in the pterin
branch of the folate synthesis pathway [39]. The precise resistance
mechanism is unclear: Nudix hydrolase acts far upstream of
dihydrofolate reductase or dihydropteroate synthase, the respec-
tive targets of trimethoprim and sulfamethoxazole that have
previously described drug-resistant variants [47]. Further research
is needed to characterize this probable new resistance mechanism.
Do occult resistance genes in rarely studied commensal
organisms threaten human health, or are they destined to remain
sequestered in host bacteria unlikely to cause infections? Although
our laboratory-designed transfer of resistance genes to the model
recipient E. coli does not prove that such transfer occurs naturally,
the ease of transferring resistance phenotypes to a model recipient
closely related to many human pathogens is concerning. While
current data are insufficient to assess the risk of commensals
transferring resistance alleles to pathogens, the presence of
functional resistance genes in healthy children that are more
diverse than previously suspected and include a mobilizable
resistance reservoir against rarely used antibiotics, is worrisome.
Our identification of tigecycline resistance in fecal samples
collected before introduction of that drug, of unanticipated
resistance function of proteins (e.g. MFS transporter in Bifidobacter-
ium longum), and of a putative novel resistance mechanism (Nudix
hydrolase) demonstrate the potential for functional metagenomics
to detect new patterns of resistance, and suggest that increased
surveillance for resistance genes in commercial organisms (i.e.
probiotics) and in human microbial communities, may be
warranted. Together, these results underscore the importance of
functional metagenomics as a complement to culture-based, PCR,
and computational resistance assays, and illustrate its promise as a
powerful tool for illuminating fecal resistome diversity and
identifying emergent resistance trends.
Methods
Subjects and Specimens
22 deidentified stools archived at 280uC since collection for a
study of fluoroquinolone resistance in healthy pediatric clinic
patients [19] were selected for investigation. Fecal donors were
infants, children, and adolescents ranging in age from one month
to 19 years (Table S1 in File S1). Samples were randomly selected
within defined age brackets. To ensure that the critical first year of
life was adequately represented, eight samples were selected from
infants ,= 12 months of age. As these were deidentified archival
specimens previously described in a prior publication [19], they
were not considered to constitute human specimens per NIH
regulations, and thus did not require additional IRB review.
Metagenomic Library Construction and Functional
Selection
Metagenomic libraries were constructed and screened as
described [48] (details in File S1). Briefly, DNA was separated
from 50–100 mg of frozen stool from each subject using bead-
beating and phenol:chloroform extraction, sheared into 2–5 kb
fragments, ligated into expression vector pZE21 [49], and
electroporated into E. coli MegaX DH10B T1R (Invitrogen).
These metagenomic libraries were screened for resistance to 18
antibiotics on Mueller-Hinton (MH) agar plates (Table S3 in File
S1).
Functionally-selected metagenomic fragments were PCR-am-
plified, sheared into ,160 bp fragments, ligated to adapters
indexed with unique 7 bp nucleotide tags, and sequenced on the
Illumina HiSeq 2000 platform. The SRA accession number for the
raw reads is SRP029439. Reads were assigned based on their
index tag (up to 96 selections sequenced per lane) before assembly
into full-length metagenomic fragments and functional annotation
using PARFuMS [18] (details in File S1). GenBank accession
numbers for the full-length metagenomic fragments are KF626669
- KF630360.
Selected metagenomic fragments without known resistance
function or with low identity to known resistance genes were
validated by PCR-amplifying the open reading frame (ORF) in
question from its library of origin (Table 2, Table S1 in File S1,
details in File S1), ligated into pZE21, transformed into MegaX
DH10B T1R, and selected on antibiotic media corresponding to
its putative phenotype. ORFs were then PCR-amplified from
colonies exhibiting a resistant phenotype and Sanger-sequenced to
verify their identity. MICs for relevant antibiotics against clones
with validated ORFs were determined via growth assays in MH
broth [50].
Statistical Analysis
Statistical analysis was performed using SAS software 9.1.3 [51].
Two-tailed Fisher’s Exact and Wilcoxon rank-sum Tests were used
to test categorical and continuous data, respectively, for statistically
significant differences between groups.
Phylogenetic Analysis
Multiple alignment of predicted protein sequences .200aa in
length was performed using MUSCLE (http://www.drive5.com/
muscle/, March 2012) and approximate maximum-likelihood
phylogenetic trees were built using FastTree (http://www.
microbesonline.org/fasttree/, March 2012) and visualized with
FigTree (http://tree.bio.ed.ac.uk/software/figtree/, March 2012).
Beta-lactamases were assigned to an Ambler class and aminogly-
coside resistance proteins were identified as aminotransferases,
phosphotransferases, or bifunctional enzymes according to the best
hit to the NCBI nr or Antibiotic Resistance Genes database
(ARDB), and by PSI-BLAST (details in File S1).
Supporting Information
Figure S1 Number and Classification of Contigs with
Known Resistance Genes. The upper graph shows the
number of contigs with a known resistance gene, separated by
antibiotic selection, on a log scale. The lower graph shows the
fraction of those contigs for each antibiotic selection condition that
have a single resistance gene, a multidrug resistance element, and
a resistance gene with a mobile element.
(TIF)
File S1 Supporting Information. Text Supplementary
Materials and Methods in File S1: Supplementary Materials and
Methods. Table S1 in File S1: Ages of fecal sample donors. Table
S2 in File S1: PCR Primers used in this study. Each primer pair is
assigned a number from 1–12 with the forward primer designated
as ‘‘A’’ and the reverse primer designated as ‘‘B’’. PCR templates
and products are listed to the right of the primer sequences. Table
S3 in File S1: Antibiotics used in functional metagenomic screens
Antibiotic concentrations were selected according to the minimum
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observed inhibitory concentration (MIC) of MegaX DH10B T1R
that had been transformed with unmodified pZE21. If the MIC for
the MegaX DH10B T1R with pZE21 was lower than the
sensitivity breakpoint for Enterobacteriaceae listed in the Clinical and
Laboratory Standards Institute (CLSI) manual, the antibiotic
concentration was set at the sensitivity breakpoint. The sole
exceptions were ciprofloxacin, which was screened at the lowest
observed MIC for MegaX DH10BT1R transformed with pZE21,
which was below the breakpoint listed in the CLSI, and
tigecycline, for which there are no standards in the CLSI manual
for dilution susceptibility testing (disk diffusion only is described). A
tigecycline concentration of 2 ug/mL was used to determine
tigecycline nonsusceptibility in our E. coli host, as this far exceeds
the reported range of susceptibility in wild-type E. coli. [53,54] All
concentrations are in ug/mL, and all antibiotics were added to
Mueller-Hinton agar with 50 ug/mL of kanamycin (MH-Kan).
Table S4 in File S1: Keywords used to categorize PARFuMS
annotations. If any term in a given category (antibiotic resistance,
transporter, or mobile element) appeared in the set of annotations
for an ORF, the entire ORF was categorized accordingly. There
was a hierarchy of categories so that the antibiotic resistance
category superseded the transporter or mobile element categories
(e.g. if one annotation was for an efflux pump, and another was for
a multidrug-resistant efflux pump, the ORF would be classified as
an antibiotic resistance gene). If an ORF was annotated with any
of the terms in the column marked ‘‘flagged for further review’’,
the ORF was reviewed manually by performing a BLASTx with
default settings against the NCBI nr database and against the
Antibiotic Resistance Genes Database (ARDB) to determine if a
resistance gene was present. Table S5 in File S1: Categories of
metagenomic fragments based on keyword search of PARFuMS
output. Each metagenomic fragment was assigned to one of the
categories listed in the left column based on the assignment of its
component ORFs, as listed in the left column. Contigs initially
assigned as ‘‘unknown’’ were BLASTed against the NCBI nr/nt
databases to identify any additional resistance genes; their ORFs
were then re-categorized and the contigs reassigned accordingly.
Table S6 in File S1: rRNA methylases identified in gentamicin
screens. Contig names are listed as well as the functional
annotation, the highest-scoring hit to the 16S rRNA methylase
ORF in the NCBI nr database, as well as the identity to the top nr
hit. The ORF from F19GE_3 was PCR-amplified and cloned into
MegaX DH10B T1R E. coli, where it was found to confer
extremely high-level resistance to amikacin and gentamicin. Table
S7 in File S1: Selected chloramphenicol resistance genes. Contigs
represented on this table were selected from the 78 total contigs
with known resistance genes against chloramphenicol, and were
included to illustrate the mechanistic diversity of chloramphenicol
resistance genes in the infant and child age groups, and to provide
interesting examples of synteny between chloramphenicol resis-
tance genes and mobilization elements. The name of the contig,
age group of the fecal donor, and annotation of the ORF
according to the top hit against the NCBI nr database are
included. Other ORFs of interest located on the same contig are
found in the ‘‘Syntenic with’’ column. Table S8 in File S1:
Selected tetracycline resistance genes. Contigs represented on this
table were selected from the 110 total contigs with known
resistance genes in this selection, and were included to illustrate
the mechanistic diversity of tetracycline resistance genes in the
infant and child age groups, and to provide interesting examples of
synteny between tetracycline resistance genes and mobilization
elements or other resistance genes. The name of the contig, age
group of the fecal donor, and annotation of the ORF according to
the top hit against the NCBI nr database are included. Other
ORFs of interest located on the same contig are found in the
‘‘Syntenic with’’ column. Table S9 in File S1: Selected tigecycline
resistance genes. Contigs on this table represent three of the seven
contigs with known resistance genes in this selection, and were
included to provide interesting examples of synteny between
tigecycline resistance genes and mobilization elements or other
resistance genes. The name of the contig, age group of the fecal
donor, and annotation of the ORF according to the top hit against
the NCBI nr database are included. Other ORFs of interest
located on the same contig are found in the ‘‘Syntenic with’’
column. Table S10 in File S1: Selected trimethoprim resistance
genes. Contigs represented on this table were selected from the
703 total contigs with known resistance genes in this selection, and
were included to illustrate the mechanistic diversity of trimetho-
prim resistance genes in the infant and child age groups, and to
provide interesting examples of synteny between trimethoprim
resistance genes and mobilization elements or other resistance
genes. The name of the contig, age group of the fecal donor, and
annotation of the ORF according to the top hit against the NCBI
nr database are included. Other ORFs of interest located on the
same contig are found in the ‘‘Syntenic with’’ column. Table S11
in File S1: Selected trimethoprim-sulfamethoxazole resistance
genes. Contigs represented on this table were selected from the
537 total contigs with known resistance genes in this selection, and
were included to illustrate the mechanistic diversity of trimetho-
prim-sulfamethoxazole resistance genes in the infant and child age
groups, and to provide interesting examples of synteny between
trimethoprim-sulfamethoxazole resistance genes and mobilization
elements or other resistance genes. The name of the contig, age
group of the fecal donor, and annotation of the ORF according to
the top hit against the NCBI nr database are included. Other
ORFs of interest located on the same contig are found in the
‘‘Syntenic with’’ column. Table S12 in File S1: Selected
cycloserine resistance genes. Contigs represented on this table
were selected from the 956 total contigs with known resistance
genes in this selection, and were included to illustrate the
mechanistic diversity of cycloserine resistance genes in the infant
and child age groups, and to provide interesting examples of
synteny between cycloserine resistance genes and mobilization
elements or other resistance genes. The name of the contig, age
group of the fecal donor, and annotation of the ORF according to
the top hit against the NCBI nr database are included. Other
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